Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Beats Estimates as Pipeline Advances Inotiv NOTV Q1 2026 Earnings EPS Falls Short Amid Operational Challenges Antero Resources Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Declines XENE Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues TPST Q1 2026 Earnings Significant EPS Miss Amid No Revenue Stock Gains 276 Enliven Therapeutics ELVN Slips 168 as Stock Tests Key Support Levels Biogen BIIB Trading Flat at 19356 Key Levels in Focus Seritage Growth Properties SRG Surges 894 Support and Resistance Levels in Focus Ategrity Specialty Insurance ASIC Modestly Gains Approaching Key Resistance CPHC Q2 2025 Earnings Net Loss Per Share of 006 Reported Stock Edges Higher